Solara, Makers Of Ibuprofen, Inspected By FDA

NEW DELHI (ANI) – The US Food and Drug Administration has completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Sciences Limited at Visakhapatnam. The facility is a green field project spread over an area of 40 acres and has dedicated facilities for the manufacture of Ibuprofen API.

The US FDA agency with their designated investigator inspected the facility from May 14-17.

The inspection established that the site is in an “Acceptable State of Compliance” with Zero Form 483 inspectional observations from the US FDA.

The company now has two FDA-inspected manufacturing sites, the other one being in Puducherry for Ibuprofen manufacture.

The facility also manufactures its key starting material for Ibuprofen and thus achieves backward integration of its critical supply chain and ensures business continuity for its customers.

—